Dachaigh › Cancer Ovarian › Indiana › Indianapolis
Sgrùdaidhean clionaigeach Cancer Ovarian ann an Indianapolis, IN
Tha 17 sgrùdaidhean airson Cancer Ovarian a’ lorg phàirtichean aig làraichean ann agus timcheall air Indianapolis (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
A’ fastadhÌre 1
- IU Simon Cancer Center, Indianapolis
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A’ fastadhÌre 2
- Indiana University Melvin and Bren Simon Cancer Center /ID# 275492, Indianapolis
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
A’ fastadhÌre 2
- Site 0284 - Community Cancer Center North, Indianapolis
- Site 0217 - St Vincent Hospital and Health Care Centers, Indianapolis
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A’ fastadhÌre 3
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
- Franciscan Health, Indianapolis
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
A’ fastadhÌre 1
- Indiana University (IU) School of Medicine, Indianapolis
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
A’ fastadhÌre 1/2
- Community Health Network, Indianapolis
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
A’ fastadhÌre 3
- Franciscan Health Indianapolis ( Site 0081), Indianapolis
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
A’ fastadhÌre 3
- Indiana University Simon Comprehensive Cancer Center, Indianapolis
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
A’ fastadhÌre 1
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
A’ fastadhÌre 1/2
- Riley Hospital for Children, Indianapolis
A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
A’ fastadhÌre 1
- Indiana University, Indianapolis
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
A’ fastadh
- Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
- Ascension Saint Vincent Indianapolis Hospital, Indianapolis
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
A’ fastadhÌre 3
- Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
- Sidney and Lois Eskenazi Hospital, Indianapolis
- Ascension Saint Vincent Indianapolis Hospital, Indianapolis
- agus 1 a bharrachd
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- Community Health Network, Indianapolis
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A’ fastadhÌre 2/3
- Community Health Network - MD Anderson, Indianapolis
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A’ fastadhÌre 1
- Community Health Network, Inc, Indianapolis
- Community Health Network, Inc., Indianapolis
- Community Health Network Investigational Drug Services, Indianapolis
- agus 1 a bharrachd
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
A’ fastadhÌre 3
- Indiana University, Indianapolis
Sgrùdaidhean Cancer Ovarian ann am bailtean eile
- Houston, TX89 sgrùdaidhean
- New York City, NY69 sgrùdaidhean
- Boston, MA61 sgrùdaidhean
- Los Angeles, CA50 sgrùdaidhean
- Nashville, TN49 sgrùdaidhean
- Arlington, VA46 sgrùdaidhean
- Philadelphia, PA44 sgrùdaidhean
- Columbus, OH39 sgrùdaidhean
- St. Louis, MO38 sgrùdaidhean
- Chicago, IL36 sgrùdaidhean
- San Antonio, TX31 sgrùdaidhean
- Cleveland, OH30 sgrùdaidhean
Sgrùdaidhean eile ann an Indianapolis
- Aillse Sgamhain Neo-chealla-beag32 sgrùdaidhean
- Aillse (gach seòrsa)24 sgrùdaidhean
- Fàilligeadh a' Chridhe23 sgrùdaidhean
- Obesity20 sgrùdaidhean
- Aillse a' bhroilleach20 sgrùdaidhean
- Ailse metastatach19 sgrùdaidhean
- Aillse colorectal18 sgrùdaidhean
- Galarachd Cardiovasculach17 sgrùdaidhean
- Ailseachadh nan Sgamhan16 sgrùdaidhean
- Diabetes Type 114 sgrùdaidhean
- Ailse Endometrial14 sgrùdaidhean
- Galar Alzheimer14 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.